outlook new era

Home China Economy Videos World Greater Bay Area Sci-Tech Culture Military Law Think Tank Photo Gallery Health Magazines

中文版 | WeChat |

List browsing
Card browsing

An innovative drug approved by FDA to delay the onset of type 1 diabetes, Tzield, was approved to first try in Boao Music City

Tzield (Teplizumab), an innovative targeted therapy approved by the US Food and Drug Administration (FDA) to delay the onset of type 1 diabetes, has been approved as a pilot test. As an import drug ur ...
Industry 2024-07-02
Ba Wang Cha Ji's first nationwide promotion of healthy tea drinking ABCD logo in its stores

In February of this year, Bawang Tea Ji's stores in Shanghai fully implemented the "Nutrition Selection" logo, becoming the first tea beverage brand in the country to use a nutrition grading system. A ...
Industry 2024-07-01
"Anti cancer miracle drug" may cause heart disease? Zhongshan Hospital Releases National First Clinical Reference Book

Nowadays, new types of anti-cancer drugs are emerging one after another, and the survival rate of cancer patients is constantly increasing. However, the cardiac toxicity of anti-tumor drugs has also b ...
Industry 2024-06-28
Is myopia surgery safe

Myopia is a common visual problem characterized by distant objects appearing blurry while nearby objects appear clear. The causes of myopia can be divided into two types: external factors and internal ...
Industry 2024-06-27
Some hospitals in Beijing are piloting a new management model of "one bed per hospital". How can "shared beds" break through the last mile of patient hospitalization?

According to the China Radio and Television Corporation's Voice of China News, on one hand, efforts are being made to meet the medical and inpatient needs of patients as much as possible, and on ...
Industry 2024-06-27
There is a new solution to "the source of all diseases", and a new treatment is coming! Smegglutide Injection Approved in China

The reduction therapy has been approved. Recently, the National Medical Products Administration (NMPA) approved the marketing application of Novo Nordisk's developed and produced Novo Nordisk (Sm ...
Industry 2024-06-26
Johnson&Johnson announces the approval of Telico in China, bringing new options for the treatment of recurrent or refractory multiple myeloma patients

Johnson&Johnson announced today that its innovative therapeutic drug, Teretozumab Injection, has been officially approved by the National Medical Products Administration. The monotherapy is suitab ...
Industry 2024-06-26
Accurate and minimally invasive diagnosis and treatment of bladder cancer to achieve domestic substitution

"We are deeply honored and proud to stand on the highest podium in China's science and technology field." Yesterday, Shenzhen Jingfeng Medical Technology Co., Ltd., as one of the main c ...
Industry 2024-06-25

Links